WallStSmart

The Boeing Company (BA)vsGenenta Science SpA ADR (GNTA)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

BA leads profitability with a 2.6% profit margin vs 0.0%. BA earns a higher WallStSmart Score of 52/100 (C-).

BA

Buy

52

out of 100

Grade: C-

Growth: 5.3Profit: 5.0Value: 3.3Quality: 3.5
Piotroski: 5/9Altman Z: 0.95

GNTA

Avoid

23

out of 100

Grade: F

Growth: 4.3Profit: 3.0Value: 5.0Quality: 6.0
Piotroski: 3/9Altman Z: -1.00
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

BASignificantly Overvalued (-50.5%)

Margin of Safety

-50.5%

Fair Value

$125.11

Current Price

$172.66

$47.55 premium

UndervaluedFair: $125.11Overvalued

Intrinsic value data unavailable for GNTA.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BA2 strengths · Avg: 9.5/10
Return on EquityProfitability
39.9%10/10

Every $100 of equity generates 40 in profit

Market CapQuality
$150.34B9/10

Large-cap with strong market position

GNTA1 strengths · Avg: 10.0/10
Price/BookValuation
0.6x10/10

Reasonable price relative to book value

Areas to Watch

BA4 concerns · Avg: 2.5/10
Profit MarginProfitability
2.6%3/10

2.6% margin — thin

Operating MarginProfitability
0.0%3/10

Operating margin of 0.0%

P/E RatioValuation
67.9x2/10

Premium valuation, high expectations priced in

Price/BookValuation
22.4x2/10

Trading at 22.4x book value

GNTA4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$30.38M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : BA

The strongest argument for BA centers on Return on Equity, Market Cap. PEG of 1.49 suggests the stock is reasonably priced for its growth.

Bull Case : GNTA

The strongest argument for GNTA centers on Price/Book.

Bear Case : BA

The primary concerns for BA are Profit Margin, Operating Margin, P/E Ratio. A P/E of 67.9x leaves little room for execution misses. Debt-to-equity of 7.52 is elevated, increasing financial risk.

Bear Case : GNTA

The primary concerns for GNTA are Revenue Growth, EPS Growth, Market Cap.

Key Dynamics to Monitor

BA carries more volatility with a beta of 1.26 — expect wider price swings.

BA is growing revenue faster at 8.0% — sustainability is the question.

BA generates stronger free cash flow (631M), providing more financial flexibility.

Monitor AEROSPACE & DEFENSE industry trends, competitive dynamics, and regulatory changes.

Bottom Line

BA scores higher overall (52/100 vs 23/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

The Boeing Company

INDUSTRIALS · AEROSPACE & DEFENSE · USA

The Boeing Company is an American multinational corporation that designs, manufactures, and sells airplanes, rotorcraft, rockets, satellites, telecommunications equipment, and missiles worldwide. The company also provides leasing and product support services.

Genenta Science SpA ADR

INDUSTRIALS · CONGLOMERATES · USA

Genenta Science SpA, a clinical-stage biotechnology company, is dedicated to the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company is headquartered in Milan, Italy.

Visit Website →

Want to dig deeper into these stocks?